These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19505408)

  • 1. Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection.
    Giannitti C; Benucci M; Caporali R; Manganelli S; Bellisai F; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(2):543-6. PubMed ID: 19505408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection.
    Bellisai F; Giannitti C; Donvito A; Galeazzi M
    Clin Rheumatol; 2007 Jul; 26(7):1127-9. PubMed ID: 17143590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.
    Roux CH; Brocq O; Breuil V; Albert C; Euller-Ziegler L
    Rheumatology (Oxford); 2006 Oct; 45(10):1294-7. PubMed ID: 16603583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
    Carroll MB; Bond MI
    Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.
    Chen YM; Chen HH; Chen YH; Hsieh TY; Hsieh CW; Hung WT; Lan JL; Chen DY
    Ann Rheum Dis; 2015 Mar; 74(3):626-7. PubMed ID: 25452310
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
    Lin KM; Cheng TT; Lin JC; Chen CJ
    Clin Rheumatol; 2015 Jun; 34(6):1039-46. PubMed ID: 25939523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept therapy in patients with psoriasis and concomitant HCV infection.
    Garavaglia MC; Altomare G
    Int J Immunopathol Pharmacol; 2010; 23(3):965-9. PubMed ID: 20943071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.
    Peterson JR; Hsu FC; Simkin PA; Wener MH
    Ann Rheum Dis; 2003 Nov; 62(11):1078-82. PubMed ID: 14583571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection.
    Parke FA; Reveille JD
    Arthritis Rheum; 2004 Oct; 51(5):800-4. PubMed ID: 15478165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
    Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
    J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.
    Markatseli TE; Alamanos Y; Saougou I; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2012; 30(1):31-8. PubMed ID: 22153557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for a patient with rheumatoid arthritis and hepatitis C.
    Giannitti C; Bellisai F; Ferri C; Galeazzi M
    Expert Opin Pharmacother; 2009 Mar; 10(4):579-87. PubMed ID: 19284361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a single center, observational study over an 8-year period.
    Conti F; Scrivo R; Spinelli FR; Truglia S; Magrini L; Di Franco M; Ceccarelli F; Valesini G
    Clin Exp Rheumatol; 2009; 27(3):540-1. PubMed ID: 19604456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.